ProCE Banner Activity

Update on Vaccine Candidates for RSV

Clinical Thought
We are closer than ever to finding an effective RSV vaccine, but recent challenges may delay approval.

Released: April 07, 2022

Expiration: April 06, 2023

No longer available for credit.

Share

Faculty

Angela Branche

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Janssen Therapeutics Division of Janssen Products

Partners

ASCP -Pharmacists

ProCE Banner

GAPNA

ProCE Banner

Faculty Disclosure

Primary Author

Angela Branche, MD, FIDSA

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Angela Branche, MD, has disclosed that she has received research support from Cyanvac, Merck, and Pfizer; has served as a consultant for AzurX Biopharma, GlaxoSmithKline, and Janssen; has served as an advisor for AzurX Biopharma, GlaxoSmithKline, and Janssen; and has served as a speaker for AzurX Biopharma, GlaxoSmithKline, and Janssen.